TY - JOUR
T1 - Expression dynamics of Crry at the implantation sites in normal pregnancy and response against miscarriage induction
AU - Kuniyoshi, Nobue
AU - Hanada, Saki
AU - Ando, Reina
AU - Yustinasari, Lita Rakhma
AU - Kuratomi, Maria
AU - Kagawa, Seizaburo
AU - Imai, Hiroyuki
AU - Kusakabe, Ken Takeshi
N1 - Publisher Copyright:
© 2023 The Japanese Society of Veterinary Science.
PY - 2023
Y1 - 2023
N2 - In mammals, immune tolerance against fetal tissue has been established for normal pregnancy progression. It is known that Crry regulates complemental activity to prevent injury of the mouse embryo and extra-embryonic tissue. This study aimed to examine the expression appearance and normal localization sites of Crry in the mouse placenta. Also, the emergency responses of Crry were verified at the time of experimental miscarriage induction. Moreover, we investigated an existing similar protein of Crry in animal placentas other than mice. Crry expression level showed a peak at day 8.5 of pregnancy. Trophoblast giant cells and decidual cells indicated a positive reaction to anti-Crry antibody. After treatments of interferon-γ, Crry expression was increased significantly in the survived implantation sites as compared with the controls. However, there was no significant difference in the miscarriage-initiated sites. It disclosed that Crry distributes from the early to middle periods of the placentas and involves complement regulation at the extraembryonic tissue and decidua basalis. Crry also showed an ability to respond to risk against external initiation for urgent miscarriage. Finally, we found anti-mouse Crry antibody-bound proteins in the placenta of many animals. It suggests a potency of Crry to make an environment of immune tolerance in many types of mammal placentas.
AB - In mammals, immune tolerance against fetal tissue has been established for normal pregnancy progression. It is known that Crry regulates complemental activity to prevent injury of the mouse embryo and extra-embryonic tissue. This study aimed to examine the expression appearance and normal localization sites of Crry in the mouse placenta. Also, the emergency responses of Crry were verified at the time of experimental miscarriage induction. Moreover, we investigated an existing similar protein of Crry in animal placentas other than mice. Crry expression level showed a peak at day 8.5 of pregnancy. Trophoblast giant cells and decidual cells indicated a positive reaction to anti-Crry antibody. After treatments of interferon-γ, Crry expression was increased significantly in the survived implantation sites as compared with the controls. However, there was no significant difference in the miscarriage-initiated sites. It disclosed that Crry distributes from the early to middle periods of the placentas and involves complement regulation at the extraembryonic tissue and decidua basalis. Crry also showed an ability to respond to risk against external initiation for urgent miscarriage. Finally, we found anti-mouse Crry antibody-bound proteins in the placenta of many animals. It suggests a potency of Crry to make an environment of immune tolerance in many types of mammal placentas.
KW - Crry
KW - complement
KW - decidual cell
KW - trophoblast giant cell
UR - http://www.scopus.com/inward/record.url?scp=85146339968&partnerID=8YFLogxK
U2 - 10.1292/jvms.22-0286
DO - 10.1292/jvms.22-0286
M3 - Article
C2 - 36450590
AN - SCOPUS:85146339968
SN - 0916-7250
VL - 85
SP - 92
EP - 98
JO - Journal of Veterinary Medical Science
JF - Journal of Veterinary Medical Science
IS - 1
ER -